Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Georgina V. Long Paolo Antonio Ascierto Ester Simeone Antoni Ribas Jean-Jacques Grob Dirk Schadendorf |
| Publication date | August 5, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |